Thoracic Radiotherapy Improves the Survival in Patients With <i>EGFR</i> -Mutated Oligo-Organ Metastatic Non–Small Cell Lung Cancer Treated With Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitors: A Multicenter, Randomized, Controlled, Phase
For patients with <i>EGFR</i>-mutated oligo-organ metastatic NSCLC treated with first-line EGFR-TKIs, concurrent TRT improves the PFS and OS, and TRAEs are acceptable and tolerable.
Authors
- Heyi Gong (ORCID: https://orcid.org/0000-0003-2680-8705)
- Haixia Song (ORCID: https://orcid.org/0009-0003-4123-1470)
- Kaixian Zhang
- Xiaqin Zhang
- Shihong Wei (ORCID: https://orcid.org/0009-0008-1211-2751)
- Haiqun Lin (ORCID: https://orcid.org/0000-0002-3114-9671)
- Hongfu Sun (ORCID: https://orcid.org/0000-0003-4638-8437)
- Gaofeng Ding (ORCID: https://orcid.org/0000-0003-3372-0533)
- Zhongtang Wang (ORCID: https://orcid.org/0000-0003-3153-6775)
- Xuezhen Ma
- Shucheng Ye (ORCID: https://orcid.org/0000-0002-0939-4312)
- Shaoshui Chen (ORCID: https://orcid.org/0000-0002-7134-9475)
- Peipei Wu (ORCID: https://orcid.org/0000-0001-6350-2970)
- Minghao Li (ORCID: https://orcid.org/0000-0002-8213-0612)
- Liping Liu (ORCID: https://orcid.org/0000-0001-6356-0978)
- Fei Chen (ORCID: https://orcid.org/0000-0002-1244-2194)
- Ping Zhang (ORCID: https://orcid.org/0000-0002-0269-104X)
- Tingting Liu (ORCID: https://orcid.org/0000-0002-5144-5179)
- Qian Zhao (ORCID: https://orcid.org/0000-0003-0304-8854)
- Yaowen Zhang (ORCID: https://orcid.org/0000-0002-2379-6174)
- Baosheng Li (ORCID: https://orcid.org/0000-0002-5390-7269)
- Jian Zhang (ORCID: https://orcid.org/0000-0002-1728-5132)
- Wei Huang (ORCID: https://orcid.org/0000-0002-7606-345X)
- Xueqin Wu (ORCID: https://orcid.org/0000-0003-3657-1529)
- Lijun Tian (ORCID: https://orcid.org/0009-0009-1517-1906)
- Dan Han (ORCID: https://orcid.org/0000-0002-0408-9175)
- Zicheng Zhang (ORCID: https://orcid.org/0000-0002-9631-4316)
- Anping Zheng (ORCID: https://orcid.org/0000-0001-6006-3554)
- Hongwei Li (ORCID: https://orcid.org/0000-0003-4137-1986)
- Yongjing Yang
- Xiangming Chen (ORCID: https://orcid.org/0000-0002-6397-0683)
- Jie Li (ORCID: https://orcid.org/0000-0001-7249-014X)
- Chengrui Fu
- Wenzhi Liu (ORCID: https://orcid.org/0000-0002-6832-4576)
- Qianqian Yuan (ORCID: https://orcid.org/0000-0002-0749-0749)
- Lifang Wang (ORCID: https://orcid.org/0000-0002-4936-4652)
- Jing Wang (ORCID: https://orcid.org/0000-0001-7431-8925)
Institutions
- Qingdao University (CN)
- Guangzhou University of Chinese Medicine (CN)
- Binzhou Medical University (CN)
- Shandong University of Aeronautics (CN)
- Sun Yat-sen University (CN)
- Shanxi Medical University (CN)
- Zhengzhou University (CN)
- Sun Yat-sen Memorial Hospital (CN)
- Jilin Province Tumor Hospital (CN)
- Shandong Tumor Hospital (CN)
- Second Hospital of Shandong University (CN)
- Jinan Central Hospital (CN)
- Gansu Provincial Hospital (CN)
- Affiliated Hospital of Qingdao University (CN)
- Jining First People's Hospital (CN)
- Tengzhou Central People's Hospital (CN)
- Taian City Central Hospital (CN)
- Affiliated Hospital of Jining Medical University (CN)
- Anyang Tumor Hospital (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- Journal of Clinical Oncology
- Published
- 2024-10-07
- DOI
- https://doi.org/10.1200/jco.23.02075
- Citations
- 29
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 12.15